Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FRAS1 related extracellular matrix 1 | 0.633 | 0.423 | 1.6E-52 |
|
phenotype | 0.210 | None | 1.000 | 3 | 0 | 2013 | 2016 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1998 | 2004 | ||||||||
|
kinesin family member 7 | 0.528 | 0.731 | 2.3E-22 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2013 | 2015 | ||||||||
|
elastin | 0.415 | 0.885 | 2.1E-14 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 1999 | 2002 | ||||||||
|
SRY-box transcription factor 7 | 0.599 | 0.577 | 3.5E-07 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 1995 | 2018 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
angiotensin II receptor type 2 | 0.496 | 0.808 | 8.2E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2000 | 2009 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 1999 | 2014 | ||||||||
|
myogenic differentiation 1 | 0.569 | 0.654 | 0.15 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
paired box 3 | 0.481 | 0.769 | 0.24 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 1999 | 2001 | ||||||||
|
NK2 homeobox 1 | 0.457 | 0.808 | 0.36 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2000 | 2007 | ||||||||
|
GATA binding protein 4 | 0.458 | 0.846 | 0.49 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2007 | 2008 | ||||||||
|
slit guidance ligand 3 | 0.623 | 0.615 | 0.75 |
|
phenotype | 0.500 | None | 1.000 | 3 | 0 | 2003 | 2014 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
insulin like growth factor binding protein 3 | 0.439 | 0.808 | 0.91 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
bone morphogenetic protein 4 | 0.422 | 0.808 | 0.96 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
insulin like growth factor binding protein 5 | 0.544 | 0.692 | 0.96 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
nuclear receptor subfamily 2 group F member 2 | 0.575 | 0.692 | 0.99 |
|
phenotype | 0.500 | None | 1.000 | 0 | 0 | 2007 | 2007 |